Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Leave A Comment

Your email address will not be published. Required fields are marked *